EFDID: 423917EFD: View Filing

Issuer: NexPoint Life Sciences DST (0001901493) - D/A

Accession: 0001920957-22-000004 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001901493
  • Entity Name:
    NexPoint Life Sciences DST
  • Entity Type:
    Other
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2021)
  • Address:
    300 CRESCENT COURT
    SUITE 700
    DALLAS, TX 75201
  • Persons:
    Related Persons 5
    N/A NexPoint Real Estate Advisors IV, L.P.
    Executive Officer 
    Sponsor of the Issuer
    Matthew Goetz
    Executive Officer 
    Authorized Signatory of the Issuer
    Matt McGraner
    Executive Officer 
    Authorized Signatory of the Issuer
    N/A NREA Casper, LLC
    Executive Officer 
    Manager and Signatory Trustee of the Issuer
    N/A NREA Casper Investment Co, LLC
    Executive Officer 
    Contributor of the Issuer
EDGAR: Offering Information
  • Accession Date:
    04/26/2022
  • First Sale Date:
    12/16/2021
  • Offering Amount:
    $107,550,012
  • Amount Sold:
    $102,190,109
  • Amount Remaining:
    $5,359,903
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AL, CA, CT, DC, GA, HI, IA, ID, IN, KS, KY, MA, MD, MN, NC, NH, NJ, NM, OH, OR, RI, TX, UT, VA, WI
Inactive:CO, IL, LA, NE, NV, TN, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Emerson Equity LLC 130032 None None CA, CO, FL, KY, TX
Maxwell Financial Group, Inc. 167863 None None CA
TCFG Wealth Management, LLC 164153 None None CT, FL
Great Point Capital LLC 114203 None None CO, IL, ME, MA, NJ, NY
Centaurus Financial, Inc. 30833 None None CA, FL, NV, NY, TN, UT
Concorde Investment Services LLC 151604 None None AL, CA, FL, GA, ID, IN, IA, LA, MA, NV, NJ, NY, OH, OR, TN, TX, UT, WA
Stax Capital 300607 None None CA, CO, HI, KS, NV, OR, WA
Thornhill Securities, Inc. 22333 None None CA, CO, FL, KS, LA, TN, TX, WA
Growth Capital Services, Inc. 124658 None None CA, FL
Lightpath Capital, Inc. 34617 None None AZ, CA, NC
McDermott Investment Services, LLC 154926 None None NJ
Innovation Partners LLC 146344 None None CA, NE
Capulent LLC 155155 None None CA, MN, NM, NC
Metropolitan Capital Investment Banc, Inc. 148820 None None CO, IL, NY, UT
American Trust Investment Services, Inc. 3001 None None CA, FL, NV, NH, OH
Patrick Capital Markets, LLC 16518 None None CA, DC, MA, VA
Wilson-Davis & Co., Inc. 3777 None None UT
Network 1 Financial Securities Inc. 13577 None None CO
Kalos Capital, Inc. 44337 None None FL, GA
Whitehall-Parker Securities, Inc. 10608 None None CA, OR, TX
FNEX Capital, LLC 166316 None None CA, MD, NC, RI
Huntwicke Securities, LLC 146993 None None MA
Dempsey Lord Smith, LLC 141238 None None FL
Stonecrest Capital Markets, Inc. 39616 None None LA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
NexPoint Life Sciences DST/s/ Matt GoetzMatt GoetzAuthorized Signatory of the Issuer2022-04-26
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jun. 06, 2022 423917: 0001901493-22-000012 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $104,959,651
Remaining: $2,590,361
D/A May. 24, 2022 423917: 0001901493-22-000011 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $104,460,836
Remaining: $3,089,176
D/A May. 10, 2022 423917: 0001901493-22-000010 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $104,310,836
Remaining: $3,239,176
D/A Apr. 26, 2022 423917: 0001920957-22-000004 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $102,190,109
Remaining: $5,359,903
D/A Apr. 19, 2022 423917: 0001901493-22-000009 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $97,837,540
Remaining: $9,712,472
D/A Apr. 05, 2022 423917: 0001901493-22-000008 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $88,993,634
Remaining: $18,556,378
D/A Mar. 22, 2022 423917: 0001901493-22-000007 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $81,810,344
Remaining: $25,739,668
D/A Mar. 08, 2022 423917: 0001901493-22-000006 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $67,932,218
Remaining: $39,617,794
D/A Feb. 23, 2022 423917: 0001901493-22-000005 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $39,896,256
Remaining: $67,653,756
D/A Feb. 10, 2022 423917: 0001901493-22-000004 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $35,001,120
Remaining: $72,548,892
D/A Jan. 26, 2022 423917: 0001901493-22-000003 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $24,235,194
Remaining: $83,314,818
D/A Jan. 18, 2022 423917: 0001901493-22-000002 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $12,757,040
Remaining: $94,792,972
D/A Jan. 04, 2022 423917: 0001901493-22-000001 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $5,269,652
Remaining: $102,280,360
D Dec. 28, 2021 423917: 0001901493-21-000001 NexPoint Life Sciences DST
Offer Amount: $107,550,012
Amount Sold: $5,199,652
Remaining: $102,350,360